Green Planet Bio Engineering Co. Ltd. (GPLB): Operating Cash Flow
-$36.5K
Year ended 2025-12-31
-$52.9K
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$36.5K | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$35.0K | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$42.7K | n/m | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | -$32.5K | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$32.9K | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$33.8K | n/m | 2021-03-31, From 2020-01-01 |
| 2019-12-31 | -$36.9K | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$40.2K | n/a | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $0 | n/a | 2019-03-01, From 2017-01-01 |
| 2016-12-31 | $0 | n/a | 2018-03-08, From 2016-01-01 |
| 2015-12-31 | $0 | n/a | 2017-03-10, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $0 | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$668 | n/a | 2014-04-15, From 2012-01-01 |
| No annual figure between 2010-12-31 and 2012-12-31. | |||
| 2010-12-31 | $920.8K | n/a | 2012-04-03, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Green Planet Bio Engineering Co. Ltd. (GPLB) | 2025-12-31 | -$36.5K | n/m |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $7.71M | n/m |
| Amgen Inc (AMGN) | 2025-12-31 | $9.96B | -13.3% |
| CEL SCI Corp (CVM) | 2025-09-30 | -$17.12M | n/m |
| Viskase Holdings, Inc. (VISK) | 2025-12-31 | -$3.01M | n/m |
| Repligen Corp (RGEN) | 2025-12-31 | $117.42M | -33.1% |
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | -$4.47M | n/m |
| Mosaic ImmunoEngineering Inc. (CPMV) | 2025-12-31 | -$111.4K | n/m |
| Bio-Techne Corp (TECH) | 2026-06-30 | $292.07M | +1.6% |
Compare GPLB, VXRT, AMGN, CVM side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗